London's Pulse: Medical Officer of Health reports 1848-1972

View report page

Lambeth 1925

[Report of the Medical Officer of Health for Lambeth Borough]

This page requires JavaScript

Local Government Board New Tables TABLE II* CASES OF INFECTIOUS DISEASE NOTIFIED WITHIN THE BOROUGH OF LAMBETH DURING THE YEAR 1925

Cholera——————————————
Diphtheria (including Membranous Croup)8361327042570471 1—333177120139618180
Erysipelas127—1197344323192318363160
Scarlet Fever10429342579684031228278180238118997
Typhus Fever——————————————
Enteric Fever (15 paratyphoid fever)25—24936???4151149
Relapsing Fever——————————————
Continued Fever1—1—————1————1
Puerperal Fever27———720——61513226
Plague——————————————
Pulmonary Tuberculosis*487—6201212111191084788713999—
Other Forms of Tuberculosis†8897311717611311222121—
Cerebro-spinal Fever (1 post-basic meningitis3111————11—1—1
Polio-myelitis acute(4 polio encephalitis acuta)6—51—_———111—35
Encephalitis Lethargica17—31247—134369
Ophthalmia Neonatorum3636——————7361644
Measles ‡7982534636145174—2761178420511652
German Measles ‡111127259672115362—21912712347516718
Malaria8———152————8——
Anthrax————————-——————
Primary Pneumonia Acuta1599241916363718353336372465
Influenzal Pneumonia Acuta87189153017792819191228

Unlit ion Hospitals Name and Situation—Hospitals of the Metropolitan Asylums Board (one situated in the Stockwell Sub-District and Stockwell Ward of the
Borough of Lambeth). Total available beds provided by the Board—8555. Number of Diseases that can be concurrently treated—All usual notifiable infectious
diseases and(partly) Measles and Whooping Cough.
* Excluding all renotifications (196) of pulmonary tuberculosis and notifications under Form C (433) and under Form D (309) of the 1912 Regulations,
† Excluding all renotifications (147) of non pulmonary tuberculosis, and notifications under Form C(74) and under Form D(69) of the 1912 Regulations
‡ Measles and German Measles became compulsorily notifiable within the Borough of Lambeth on January 1st, 1916, and are still compulsorily notifiab